Increased risk of end-stage renal disease among hip fracture patients

Background: Inflammation-related microvasculr disease, albuminuria, and rapid deterioration of renal function can accelerate the development of end-stage renal disease (ESRD). The role of hip fracture (HFr), a disorder that involves inflammation, in the development of ESRD has not been fully investigated. This study explored whether HFr increases the risk of ESRD. Methods: Taiwan National Health Insurance inpatient claims were used to identify 83,550 patients newly diagnosed with HFr from 2000 to 2006, and 83,550 age-and sex-matched patients without HFr were randomly selected for comparison. Hazards of ESRD combined with HFr, comorbidities, including hypertension, hyperlipidemia, peripheral arterial disease, osteoporosis and asthma, and general health status, with Charlson comorbidity index (CCI), were assessed using data to the end of 2011. Results: ESRD risk was 1.42-fold higher (95% confidence interval [CI]: 1.29-1.33) in the HFr cohort than in the control group, which was computed using the Cox proportional model. Age-specific analysis revealed that the adjusted hazard ratios (aHRs) of ESRD for HFr patients increased slightly as age increased, with an aHR of 1.56 ( 95% CI: 1.35-1.81) for patients 65-74 years old, which gradually decreased to 0.88 (95% CI: 0.66-1.18) for patients >= 85 years old. ESRD risk increased as HFr severity increased, with an aHR of 6.71 (95% CI: 5.90-7.63) for patients with severe HFr. Conclusion: This study is the first to report that HFr, in combination with underlying osteoporosis-related chronic illness, microvascular disease and chronic inflammation, is associated with an increased risk of ESRD, particularly among relatively younger people. (C) 2014 European Federation of Internal Medicine. Published by Elsevier B. V. All rights reserved.